VKTX
#1425
Viking Therapeutics, Inc. - Common Stock
37.6 0 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.36%
Variación mensual
+29.03%
Variación en los últimos 6 meses
+8.92%
Cambio anual
+18.43%
Cierres anteriores
38.1 2
Open
37.9 1
Mínimo
37.3 8
High
38.4 9
Volumen
327
Financials
- Market Capitalization 4.37 B
- Employee 59
- Founded 2012
- CEO Brian Lian
- Website www.vikingtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG006LGV869
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1395 |  VCYT Veracyte, Inc. - Common Stock | 57.34 USD | -0.24% | -0.10% | +20.87% | +55.39% | 4.58 B USD | ||
| 1424 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 38.76 USD | -6.08% | -5.35% | +9.37% | +154.50% | 4.17 B USD | ||
| 1436 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.01 USD | -1.92% | -3.02% | +18.53% | +13.99% | 4.28 B USD | ||
| 1463 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.50 USD | -11.25% | -7.73% | +7.50% | +45.33% | 3.73 B USD |